TOP > 外国特許検索 > MEDICINAL COMPOSITION FOR TREATING AND/OR PREVENTING ESOPHAGEAL STENOSIS

MEDICINAL COMPOSITION FOR TREATING AND/OR PREVENTING ESOPHAGEAL STENOSIS

外国特許コード F160008846
整理番号 S2014-1359-C0
掲載日 2016年9月14日
出願国 世界知的所有権機関(WIPO)
国際出願番号 2015JP072385
国際公開番号 WO 2016024524
国際出願日 平成27年8月6日(2015.8.6)
国際公開日 平成28年2月18日(2016.2.18)
優先権データ
  • 特願2014-164429 (2014.8.12) JP
発明の名称 (英語) MEDICINAL COMPOSITION FOR TREATING AND/OR PREVENTING ESOPHAGEAL STENOSIS
発明の概要(英語) Provided is a medicinal composition for treating and/or preventing esophageal stenosis that comprises an HGF protein as an active ingredient, wherein said HGF protein is one of the following polypeptides: (a) a polypeptide comprising an amino acid sequence represented by SEQ ID NO:2; (b) a polypeptide comprising an amino acid sequence derived from the amino acid sequence represented by SEQ ID NO:2 by deletion, substitution or addition of one to several amino acids; and (c) a polypeptide comprising an amino acid sequence having a 90% or more identity with the amino acid sequence represented by SEQ ID NO:2. Also provided is a stent that comprises the medicinal composition.
特許請求の範囲(英語) [claim1]
1. Liver cell growth factor (HGF) it contains the protein, as the active ingredient esophagus strangulation remedy and/or the medicine composition in order to prevent.
[claim2]
2. Esophagus strangulation, is esophagus strangulation after the endoscope mucous membrane lower stratum exfoliation technique, in claim 1 the medicine composition of statement.
[claim3]
3. The HGF protein, is the human HGF protein, in claim 1 or 2 the medicine composition of statement.
[claim4]
4. The HGF protein rearranges, and it is the HGF protein, either of the claim 1-3 in 1 sections the medicine composition of statement.
[claim5]
5. HGF protein,
(A) The polypeptide which includes the amino acid arrangement which is shown with SEQ ID NO 2,
(B) The polypeptide which includes the amino acid arrangement where 1 or several amino acids is deficient at the time of amino acid arranging which is shown with SEQ ID NO 2, is substituted or is added, or
(C) The polypeptide which includes the amino acid arrangement which is shown with SEQ ID NO 2 and the amino acid arrangement which possesses the identity of 90% or more,
It is each polypeptide, either of the claim 1-4 in 1 sections the medicine composition of statement.
[claim6]
6. Esophagus strangulation originates in the esophagus ulcer, either of the claim 1-5 in 1 sections the medicine composition of statement.
[claim7]
7. The esophagus ulcer is restored, either of the claim 1-6 in 1 sections the medicine composition of statement.
[claim8]
8. Either of the claim 1-7 [sutento] which includes the medicine composition of statement in 1 sections.
  • 出願人(英語)
  • ※2012年7月以前掲載分については米国以外のすべての指定国
  • KAGOSHIMA UNIVERSITY
  • 発明者(英語)
  • IDO AKIO
  • TSUBOUCHI HIROHITO
  • KOMAKI YUGA
国際特許分類(IPC)
指定国 National States: AE AG AL AM AO AT AU AZ BA BB BG BH BN BR BW BY BZ CA CH CL CN CO CR CU CZ DE DK DM DO DZ EC EE EG ES FI GB GD GE GH GM GT HN HR HU ID IL IN IR IS KE KG KN KP KR KZ LA LC LK LR LS LU LY MA MD ME MG MK MN MW MX MY MZ NA NG NI NO NZ OM PA PE PG PH PL PT QA RO RS RU RW SA SC SD SE SG SK SL SM ST SV SY TH TJ TM TN TR TT TZ UA UG US UZ VC VN ZA ZM ZW
ARIPO: BW GH GM KE LR LS MW MZ NA RW SD SL SZ TZ UG ZM ZW
EAPO: AM AZ BY KG KZ RU TJ TM
EPO: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
OAPI: BF BJ CF CG CI CM GA GN GQ GW KM ML MR NE SN ST TD TG
特許の内容に興味を持たれた方、ライセンスをご希望の方は、下記「問合せ先」までお問い合わせください。

PAGE TOP

close
close
close
close
close
close